Rights and permissions
About this article
Cite this article
SMC OK's atazanavir, rabeprazole, valsartan/hydrochlorothiazide . . .. Pharmacoecon. Outcomes News 463, 3 (2004). https://doi.org/10.2165/00151234-200404630-00005
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200404630-00005